Suppr超能文献

一个非编码变异在 GANAB 中解释了一个大家族中的孤立性多囊肝病(PCLD)。

A noncoding variant in GANAB explains isolated polycystic liver disease (PCLD) in a large family.

机构信息

Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.

Department of Genetics, Yale University School of Medicine, New Haven, Connecticut.

出版信息

Hum Mutat. 2018 Mar;39(3):378-382. doi: 10.1002/humu.23383. Epub 2018 Jan 24.

Abstract

Expanded mutation detection and novel gene discovery for isolated polycystic liver disease (PCLD) are necessary as 50% of cases do not have identified mutations in the seven published disease genes. We investigated a family with five affected siblings for which no loss-of-function variants were identified by whole exome sequencing analysis. SNP genotyping and linkage analysis narrowed the candidate regions to ∼8% of the genome, which included two published PCLD genes in close proximity to each other, GANAB and LRP5. Based on these findings, we re-evaluated the exome sequencing data and identified a novel intronic nine base pair deletion in the vicinity of the GANAB exon 24 splice donor that had initially been discarded by the sequence analysis pipelines. We used a minigene assay to show that this deletion leads to skipping of exon 24 in cell lines and primary human cholangiocytes. These findings prompt genomic evaluation beyond the coding region to enhance mutation detection in PCLD and to avoid premature implication of other genes in linkage disequilibrium.

摘要

扩大对孤立性多囊肝病(PCLD)的基因突变检测和新基因发现是必要的,因为 50%的病例在七个已发表的疾病基因中没有发现突变。我们研究了一个有五个受影响兄弟姐妹的家系,全外显子组测序分析未发现功能丧失变异。SNP 基因分型和连锁分析将候选区域缩小到基因组的约 8%,其中包括两个靠近彼此的已发表的 PCLD 基因,GANAB 和 LRP5。基于这些发现,我们重新评估了外显子组测序数据,并在 GANAB 外显子 24 剪接受体附近鉴定出一个新的内含子 9 个碱基对缺失,该缺失最初被序列分析管道丢弃。我们使用小基因实验表明,这种缺失导致细胞系和原代人胆管细胞中外显子 24 的跳过。这些发现提示对基因组编码区以外进行基因评估,以增强 PCLD 的突变检测,并避免过早将其他基因与连锁不平衡联系起来。

相似文献

4
Novel GANAB variants associated with polycystic liver disease.与多囊肝疾病相关的新型 GANAB 变异体。
Orphanet J Rare Dis. 2020 Oct 23;15(1):302. doi: 10.1186/s13023-020-01585-4.

引用本文的文献

5
Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.多囊肝病:病理生理学、诊断与治疗
Hepat Med. 2022 Sep 29;14:135-161. doi: 10.2147/HMER.S377530. eCollection 2022.
6
Molecular Mechanisms of Isolated Polycystic Liver Diseases.孤立性多囊肝病的分子机制
Front Genet. 2022 Apr 26;13:846877. doi: 10.3389/fgene.2022.846877. eCollection 2022.
7
Genetics, pathobiology and therapeutic opportunities of polycystic liver disease.多囊肝疾病的遗传学、病理生物学和治疗机会。
Nat Rev Gastroenterol Hepatol. 2022 Sep;19(9):585-604. doi: 10.1038/s41575-022-00617-7. Epub 2022 May 13.
10
Polycystic Liver Disease: Advances in Understanding and Treatment.多囊性肝病:理解与治疗的新进展。
Annu Rev Pathol. 2022 Jan 24;17:251-269. doi: 10.1146/annurev-pathol-042320-121247. Epub 2021 Nov 1.

本文引用的文献

2
UniProt: the universal protein knowledgebase.通用蛋白质知识库:UniProt
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169. doi: 10.1093/nar/gkw1099. Epub 2016 Nov 29.
5
A global reference for human genetic variation.人类遗传变异的全球参考。
Nature. 2015 Oct 1;526(7571):68-74. doi: 10.1038/nature15393.
9
Polycystin-1: a master regulator of intersecting cystic pathways.多囊蛋白-1:交叉性囊性通路的主要调节因子。
Trends Mol Med. 2014 May;20(5):251-60. doi: 10.1016/j.molmed.2014.01.004. Epub 2014 Jan 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验